D. Anderson & Company Appoints Dan McDonald Vice President of Strategic and Product Development

D. Anderson & Company (DAC), a subsidiary of D. L. Anderson International, announced today that Dan McDonald has been named Vice President of Strategic and Product Development. In this newly created position, Mr. McDonald will be responsible for planning and implementing strategies to generate new business opportunities, develop new product offerings and coordinate sales efforts associated with these endeavors.

Mr. McDonald formerly served as Vice President and General Manager for Thomson CenterWatch in Boston, Mass. During his eight-year tenure at CenterWatch, he was responsible for strategic and financial planning, operations, new product initiatives, business development, sales and marketing.

“We are very excited to have someone of Dan’s caliber join our team,” said DAC President and CEO Diana Anderson, Ph.D. “He has a wealth of expertise and industry knowledge related to the clinical trials sector and is a respected professional and thought leader. He will be a great asset to our organization.”

“This is an excellent opportunity to join a leader in the field of patient recruitment and I’m looking forward to the many challenges and opportunities that lie ahead,” said Mr. McDonald.

In addition to his previous responsibilities, Mr. McDonald has authored many articles for key industry publications, is a regular speaker at industry conferences and has conducted numerous workshops regarding patient recruitment for clinical trials. Mr. McDonald holds a Bachelor of Science degree from the University of Massachusetts – School of Business Management and is a member of the Drug Information Association (DIA) and the Association of Clinical Research Professionals (ACRP).


About D. L. Anderson International, Inc.:

D. L. Anderson International, Inc. is the parent company of D. Anderson & Company (DAC), which is a leading provider of patient recruitment and retention services for the clinical trials industry with more than 14 years of experience in more than 30 countries. DAC evolved from a clinical background starting as a Site Management Organization (SMO) giving the company a unique understanding of how clinical research sites operate and what they need to reach enrollment goals within targeted timelines. DAC combines strategic marketing, messaging and branding solutions with proven, data-driven methodologies to create targeted patient recruitment campaigns for some of the most prestigious pharmaceutical and biotechnology companies in the world. DAC is a certified Women-Owned Business (WBE) by the Women’s Business Enterprise National Council and is based in Dallas, TX. Visit their website at http://www.dandersoncompany.com.